Insider Transactions in Q4 2024 at Liquidia Corp (LQDA)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 28
2024
|
Jason Adair Chief Business Officer |
BUY
Open market or private sale
|
Direct |
459
+0.39%
|
$5,049
$11.31 P/Share
|
|
Oct 18
2024
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,526
-1.22%
|
$27,786
$11.19 P/Share
|
|
Oct 14
2024
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,527
-0.99%
|
$16,797
$11.11 P/Share
|
|
Oct 14
2024
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,260
-1.08%
|
$24,860
$11.11 P/Share
|
|
Oct 14
2024
|
Russell Schundler General Counsel |
SELL
Open market or private sale
|
Direct |
2,576
-0.53%
|
$28,336
$11.11 P/Share
|
|
Oct 14
2024
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,146
-0.96%
|
$12,606
$11.11 P/Share
|
|
Oct 14
2024
|
Roger Jeffs Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,053
-0.98%
|
$88,583
$11.11 P/Share
|
|
Oct 14
2024
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
3,892
-1.24%
|
$42,812
$11.11 P/Share
|
|
Oct 11
2024
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,906
+3.16%
|
-
|